We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
On March 25, 2017, West team members participated in the Girls Exploring Tomorrow’s Technology (GETT) Expo, a STEM career exploration event for girls in Grades 5 - 10. West sponsored the event which took place at West Chester East High School in West Chester, Pennsylvania. Employees representing a variety of functions within the business helped to staff the booth.
Statistics show that young women are not embracing careers in technology, despite an increasing need for skilled professionals in science, technology, engineering and math (STEM) fields. West has partnered with the STEM Academy in Downingtown, PA to share how careers in the STEM field can be fulfilling, fun and rewarding—personally, professionally and financially. The STEM Academy is an International Baccalaureate (IB) World School offering every student the opportunity to earn an IB Diploma. The curriculum creates an environment where students are engaged in rigorous, challenging academic work.
West’s booth provided an opportunity to learn about STEM career paths, and hear from West professionals about their diverse backgrounds. Attendees were able to participate in a “Density and Viscosity” STEM activity, demonstrating how syringe use can be difficult with the viscosity of certain drugs. The activity showed them how our SmartDose® Platform offers a truly patient-centric approach to drug self-administration.
West’s Community Affairs team was also in attendance, supporting West’s philanthropic culture by bringing several dogs from Canine Partners for Life (CPL). West has a strong bond with CPL as our employees have donated thousands of hours helping train service dogs. Over 30 dogs have spent a part of their training time at West’s Exton facility.
To learn more about West’s Philanthropic mission, visit the Culture of Giving section on our website.
SmartDose® is a registered trademark of Medimop Medical Projects, Ltd., a subsidiary of West Pharmaceutical Services, Inc.West seeks partners for its SmartDose technology platform. These platforms are intended to be used as an integrated system with drug filling and final assembly completed by the pharmaceutical/biotechnology company.
Microneedles have been around for the past two decades; however, recent advances in technology have enabled their manufacturing in a variety of different forms and at lower cost than previously possible. The technologies, ranging from hollow, solid, coated to dissolving, have captured the interest of many vaccine and drug manufacturers as an alternate form of delivery primarily due to the potential advantages associated with transdermal and intradermal delivery.<br />
West has recently converted its Elastomer Formulation Drug Master Files (DMFs) to an electronic (eCTD) format.
As the adoption and acceptance of self-administered therapies grows, patients are spending less time with physicians and are playing a greater role in the delivery and management of their treatments. With the growing demand for extended-release and high-concentration formulations, more drug delivery systems choices are now available to differentiate drug products in a crowded market. Patient preferences can drive the selection of self-injection systems for a drug therapy. Selecting a system that patients prefer can, simplify use and increase compliance with the dosage regimen.
The pharmaceutical industry’s focus on extractables and leachables from packaging/delivery systems began during the mid-1990’s. Today’s regulatory agencies are more educated about the process, and drug product formulations have become more complex, which makes the need for robust extractables and leachables programs more critical than ever. In fact, failure to properly evaluate extractables and leachables has had a negative impact on many pharmaceutical companies, e.g., late-stage stability failures, submission delays, and recalls. To avoid this, the first question to ask is – “where do I start?”
The current pharmaceutical market has faced a variety of challenges, including increasing expectations for quality from end-users and regulatory agencies driven by concern for patient safety. While pharmaceutical companies are working to assure that new quality and compliance paradigms are met, a balance must be achieved between the reality of managing costs to provide a product that meets payer’s requirements and facilitating profitability in order to continue adequate business reinvestment.
English
Chinese
